Annual Revenue
$449.60 K
+$265.40 K+144.08%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual revenue is currently $449.60 thousand, with the most recent change of +$265.40 thousand (+144.08%) on 01 December 2023. During the last 3 years, it has fallen by -$512.10 thousand (-53.25%). LIPO annual revenue is now -53.25% below its all-time high of $961.70 thousand, reached on 01 December 2020.LIPO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$80.40 K
0.00%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly revenue is currently $80.40 thousandOver the past year, it has dropped by -$40.40 thousand (-33.44%). LIPO quarterly revenue is now -56.35% below its all-time high of $184.20 thousand, reached on 31 December 2022.LIPO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$201.20 K
0.00%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock TTM revenue is currently $201.20 thousandOver the past year, it has dropped by -$23.70 thousand (-10.54%). LIPO TTM revenue is now -30.21% below its all-time high of $288.30 thousand, reached on 01 September 2023.LIPO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -33.4% | -10.5% |
| 3 y3 years | -53.3% | +210.4% | -22.4% |
| 5 y5 years | - | - | - |
LIPO Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -53.3% | +144.1% | -56.4% | +210.4% | -30.2% | at low |
| 5 y | 5 years | -53.3% | +144.1% | -56.4% | +210.4% | -30.2% | +138.1% |
| alltime | all time | -53.3% | +144.1% | -56.4% | +210.4% | -30.2% | +138.1% |
Lipella Pharmaceuticals Common Stock Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $80.40 K(-33.4%) | $201.20 K(-10.5%) |
| Dec 2023 | $449.60 K(+144.1%) | $120.80 K(+16.0%) | $224.90 K(-22.0%) |
| Sept 2023 | - | $104.10 K(-43.5%) | $288.30 K(+32.7%) |
| Dec 2022 | $184.20 K(-29.0%) | $184.20 K(+456.5%) | $217.30 K(+4.5%) |
| Mar 2022 | - | $33.10 K | $208.00 K |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $259.30 K(-73.0%) | - | - |
| Dec 2021 | - | $25.90 K(-82.6%) | $259.40 K(+11.1%) |
| June 2021 | - | $149.00 K(+76.3%) | $233.50 K(+176.3%) |
| Mar 2021 | - | $84.50 K | $84.50 K |
| Dec 2020 | $961.70 K | - | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual revenue?
- What is the all time high annual revenue for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly revenue?
- What is the all time high quarterly revenue for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly revenue year-on-year change?
- What is Lipella Pharmaceuticals Common Stock TTM revenue?
- What is the all time high TTM revenue for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock TTM revenue year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual revenue?
The current annual revenue of LIPO is $449.60 K
What is the all time high annual revenue for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual revenue is $961.70 K
What is Lipella Pharmaceuticals Common Stock quarterly revenue?
The current quarterly revenue of LIPO is $80.40 K
What is the all time high quarterly revenue for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly revenue is $184.20 K
What is Lipella Pharmaceuticals Common Stock quarterly revenue year-on-year change?
Over the past year, LIPO quarterly revenue has changed by -$40.40 K (-33.44%)
What is Lipella Pharmaceuticals Common Stock TTM revenue?
The current TTM revenue of LIPO is $201.20 K
What is the all time high TTM revenue for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high TTM revenue is $288.30 K
What is Lipella Pharmaceuticals Common Stock TTM revenue year-on-year change?
Over the past year, LIPO TTM revenue has changed by -$23.70 K (-10.54%)